Comparison of the relative expression of exon 3 deleted estrogen
receptor (ER) variant (ERD3) messenger RNA between breast tumor and adjacent
matched normal breast samples. (A) Total RNA extracted from frozen
tissue sections from tumor (T) and adjacent normal (N) breast tissue samples
was reverse transcribed and polymerase chain reaction (PCR) amplified using D5U
and D5L primers. Radioactive PCR products were separated on a 6% acrylamide gel
and visualized by autoradiography. Bands that migrated at 483 and 344 base
pairs were identified as corresponding to wild-type (WT)-ER and exon 5 deleted
ER variant (ERD5) messenger RNA, respectively. C, negative control (no
complementary DNA added during the PCR reaction). (B) For each case,
signals corresponding to ERD5 variant messenger RNA were quantified and
expressed in arbitrary units for tumor (black column) and normal (white column)
components. For each sample, the mean and the standard deviation of at least
three different PCR assays are indicated. Cases are sorted by ER status (black
bottom lane) and progesterone receptor (PR) status (gray bottom lane). Samples
that failed to have three measurable signals in the four experiments performed
in both normal and neoplastic components were not included in the statistical
analysis. The significance of the differences between tumor and normal matched
components within each subgroup, as tested using the Wilcoxon matched-pair
test, is indicated where P <0.05. m, molecular weight marker.